Similarly, bintrafusp alfa is able to mediate neutralization of PD-L1 and TGF-β in the TME, leading to alleviation of local tumor immunosuppression mediated by both pathways, including the reversion of tumor mesenchymal features for improved susceptibility to immune attack [15,17]. The gene discussed is CD274; the disease is neoplasm.